UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
+$335M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$221M |
| 3 |
Zimmer Biomet
ZBH
|
+$207M |
| 4 |
Ecolab
ECL
|
+$200M |
| 5 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$199M |
Top Sells
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$267M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$223M |
| 3 |
AGN
ALLERGAN INC
AGN
|
+$221M |
| 4 |
Apple
AAPL
|
+$207M |
| 5 |
American Express
AXP
|
+$170M |
Sector Composition
| 1 | Healthcare | 16.57% |
| 2 | Technology | 14.69% |
| 3 | Financials | 14.16% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Industrials | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SQNM
951
DELISTED
SEQUENOM INC NEW
SQNM
| $6.49M | 0.01% |
1,641,796
+2,500
| +0.2% | +$9.88K |
|
952
Vanguard FTSE Developed Markets ETF
VEA
$175B
| $6.47M | 0.01% |
162,534
-317,514
| -66% | -$12.6M |
|
|
X
953
DELISTED
US Steel
X
| $6.47M | 0.01% |
265,125
+11,584
| +5% | +$283K |
|
954
Brixmor Property Group
BRX
$8.51B
| $6.47M | 0.01% |
243,646
+44,314
| +22% | +$1.18M |
|
955
Atara Biotherapeutics
ATRA
$82.7M
| $6.41M | 0.01% |
6,165
+3,873
| +169% | +$4.03M |
|
|
ACHN
956
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $6.3M | 0.01% |
638,459
+10,200
| +2% | +$101K |
|
957
RLJ Lodging Trust
RLJ
$1.14B
| $6.27M | 0.01% |
200,273
+8,900
| +5% | +$279K |
|
958
Saia
SAIA
$8.41B
| $6.26M | 0.01% |
141,298
-71,900
| -34% | -$3.19M |
|
|
RPAI
959
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $6.23M | 0.01% |
388,772
-4,257
| -1% | -$68.2K |
|
|
FCE.A
960
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $6.23M | 0.01% |
244,212
+5,015
| +2% | +$128K |
|
961
Fortune Brands Innovations
FBIN
$7.05B
| $6.19M | 0.01% |
152,546
-2,508
| -2% | -$102K |
|
962
Reinsurance Group of America
RGA
$12.7B
| $6.19M | 0.01% |
66,410
+1,500
| +2% | +$140K |
|
963
Community Health Systems
CYH
$409M
| $6.14M | 0.01% |
142,021
-282,422
| -67% | -$12.2M |
|
964
Banco Santander Chile
BSAC
$12.2B
| $6.13M | 0.01% |
282,639
+94,400
| +50% | +$2.05M |
|
965
United Therapeutics
UTHR
$18.3B
| $6.08M | 0.01% |
35,272
+6,385
| +22% | +$1.1M |
|
966
Essent Group
ESNT
$6.24B
| $6.04M | 0.01% |
252,682
-4,400
| -2% | -$105K |
|
967
Huntington Ingalls Industries
HII
$10.7B
| $5.94M | 0.01% |
42,367
-14,025
| -25% | -$1.97M |
|
968
Wipro
WIT
$29.4B
| $5.89M | 0.01% |
+2,357,333
| New | +$5.89M |
|
969
Baytex Energy
BTE
$1.83B
| $5.87M | 0.01% |
371,285
+25,052
| +7% | +$396K |
|
|
EQC
970
DELISTED
Equity Commonwealth
EQC
| $5.84M | 0.01% |
220,013
+4,900
| +2% | +$130K |
|
971
Ambev
ABEV
$35.7B
| $5.82M | 0.01% |
1,010,400
+59,600
| +6% | +$343K |
|
|
KEYW
972
DELISTED
The KEYW Holding Corporation
KEYW
| $5.76M | 0.01% |
700,395
-8,000
| -1% | -$65.8K |
|
973
Arthur J. Gallagher & Co
AJG
$75.2B
| $5.76M | 0.01% |
123,269
+6,407
| +5% | +$300K |
|
974
Vail Resorts
MTN
$5.37B
| $5.63M | 0.01% |
54,469
-3,869
| -7% | -$400K |
|
|
BRLI
975
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $5.62M | 0.01% |
159,340
+36,500
| +30% | +$1.29M |
|